05. Augmentation With Second-Generation Antipsychotics

Learning Objectives:

After completing this activity, the learner will be able to:

1. Identify and update pharmacological interventions for treatment-resistant depression and their evidence base
2. Describe the role of experimental treatments and neuromodulation in the management of TRD

Original Release Date: 01/07/2017

Expiration Date: 04/01/2021

Relevant Financial Disclosures:

None of the faculty, planners, and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com